Ramsay Health Care Limited Logo

Ramsay Health Care Limited

RMYHY

(2.0)
Stock Price

6,31 USD

1.78% ROA

19.18% ROE

11.09x PER

Market Cap.

11.800.232.118,57 USD

286.09% DER

0.93% Yield

5.4% NPM

Ramsay Health Care Limited Stock Analysis

Ramsay Health Care Limited Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Ramsay Health Care Limited Fundamental Stock Analysis
# Analysis Rating
1 Revenue Growth

This company's revenue has experienced steady growth over the last five years, indicating a reliable and prosperous financial trajectory.

2 Assets Growth

Over the past five years, this company's revenue has consistently increased, demonstrating a robust financial performance that makes it an appealing opportunity.

3 ROE

The stock's ROE falls within an average range (7.48%), demonstrating satisfactory profitability and efficiency in utilizing shareholders' equity.

4 ROA

The stock's ROA (2.18%) shows that it's doing a pretty good job at making money from its assets, making it a solid choice to invest and earn steady profits.

5 Dividend

The company has consistently provided dividends over the past three years, indicating a reliable source of income for investors.

6 Buffet Intrinsic Value

The company's stock presents an enticing opportunity as it appears undervalued (536) by Warren Buffett's formula, indicating that its intrinsic value exceeds the market price.

7 PBV

The stock's high Price-to-Book Value (P/BV) ratio (3.13x) suggests it's overvalued, potentially making it an expensive investment.

8 DER

The company has a high debt to equity ratio (272%), which means it owes a lot of money compared to what it actually owns, making it financially risky.

9 Net Profit Growth

The net profit of this company has shown no signs of growth over the last five years, suggesting limited profitability and making it a less attractive investment opportunity.

10 Graham Number

The Graham number analysis indicates that this company's stock price is likely overpriced, raising concerns about its investment potential.

11 Dividend Growth

Potential investors should be aware that the company's dividend growth has shown no upward trend in the past three years, indicating limited potential for increased returns.

Ramsay Health Care Limited Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Ramsay Health Care Limited Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Buy
3 RSI Hold
4 Stoch RSI Buy

Ramsay Health Care Limited Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Ramsay Health Care Limited Revenue
Year Revenue Growth
1996 194.261.000
1997 0 0%
1998 0 0%
1999 0 0%
2000 377.012.000 100%
2001 549.792.000 31.43%
2002 655.500.000 16.13%
2003 760.842.000 13.85%
2004 1.431.812.000 46.86%
2005 1.983.457.000 27.81%
2006 2.086.825.000 4.95%
2007 2.651.230.000 21.29%
2008 3.199.946.000 17.15%
2009 3.374.130.000 5.16%
2010 3.692.975.000 8.63%
2011 3.919.172.000 5.77%
2012 4.134.064.000 5.2%
2013 4.876.232.000 15.22%
2014 7.319.517.000 33.38%
2015 8.647.623.000 15.36%
2016 8.667.179.000 0.23%
2017 9.136.626.000 5.14%
2018 11.512.770.000 20.64%
2019 11.932.800.000 3.52%
2020 12.348.300.000 3.36%
2021 13.082.100.000 5.61%
2022 14.886.400.000 12.12%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Ramsay Health Care Limited Research and Development Expenses
Year Research and Development Expenses Growth
1996 0
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 10.000.000 100%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Ramsay Health Care Limited General and Administrative Expenses
Year General and Administrative Expenses Growth
1996 0
1997 0 0%
1998 0 0%
1999 0 0%
2000 224.942.000 100%
2001 311.657.000 27.82%
2002 387.431.000 19.56%
2003 445.591.000 13.05%
2004 834.783.000 46.62%
2005 1.132.040.000 26.26%
2006 1.202.077.000 5.83%
2007 1.538.238.000 21.85%
2008 1.822.250.000 15.59%
2009 1.901.115.000 4.15%
2010 2.069.903.000 8.15%
2011 2.203.162.000 6.05%
2012 2.327.003.000 5.32%
2013 2.826.479.000 17.67%
2014 4.337.076.000 34.83%
2015 5.165.509.000 16.04%
2016 5.207.239.000 0.8%
2017 5.660.225.000 8%
2018 7.171.236.000 21.07%
2019 7.571.800.000 5.29%
2020 7.817.600.000 3.14%
2021 8.309.500.000 5.92%
2022 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Ramsay Health Care Limited EBITDA
Year EBITDA Growth
1996 194.261.000
1997 38.092.000 -409.98%
1998 20.175.000 -88.81%
1999 29.363.000 31.29%
2000 35.551.000 17.41%
2001 83.416.000 57.38%
2002 91.680.000 9.01%
2003 101.259.000 9.46%
2004 154.212.000 34.34%
2005 264.891.000 41.78%
2006 281.085.000 5.76%
2007 319.664.000 12.07%
2008 368.851.000 13.34%
2009 447.474.000 17.57%
2010 503.829.000 11.19%
2011 565.245.000 10.87%
2012 601.724.000 6.06%
2013 694.883.000 13.41%
2014 1.067.577.000 34.91%
2015 1.221.822.000 12.62%
2016 1.252.862.000 2.48%
2017 1.144.712.000 -9.45%
2018 1.508.993.000 24.14%
2019 1.484.600.000 -1.64%
2020 1.826.400.000 18.71%
2021 1.624.200.000 -12.45%
2022 225.400.000 -620.59%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Ramsay Health Care Limited Gross Profit
Year Gross Profit Growth
1996 194.261.000
1997 0 0%
1998 0 0%
1999 0 0%
2000 272.987.000 100%
2001 392.490.000 30.45%
2002 471.730.000 16.8%
2003 544.088.000 13.3%
2004 1.048.673.000 48.12%
2005 1.459.886.000 28.17%
2006 1.456.467.000 -0.23%
2007 1.835.065.000 20.63%
2008 2.168.696.000 15.38%
2009 2.287.446.000 5.19%
2010 2.531.980.000 9.66%
2011 2.715.830.000 6.77%
2012 2.880.440.000 5.71%
2013 3.463.598.000 16.84%
2014 5.649.192.000 38.69%
2015 6.640.843.000 14.93%
2016 6.669.105.000 0.42%
2017 7.004.031.000 4.78%
2018 8.920.633.000 21.49%
2019 9.209.700.000 3.14%
2020 9.339.600.000 1.39%
2021 9.974.300.000 6.36%
2022 712.800.000 -1299.31%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Ramsay Health Care Limited Net Profit
Year Net Profit Growth
1996 -2.083.000
1997 13.961.000 114.92%
1998 5.964.000 -134.09%
1999 6.616.000 9.85%
2000 16.004.000 58.66%
2001 31.071.000 48.49%
2002 37.055.000 16.15%
2003 0 0%
2004 -327.000 100%
2005 87.590.000 100.37%
2006 107.056.000 18.18%
2007 92.198.000 -16.12%
2008 106.473.000 13.41%
2009 148.282.000 28.2%
2010 198.375.000 25.25%
2011 244.105.000 18.73%
2012 266.404.000 8.37%
2013 303.759.000 12.3%
2014 385.542.000 21.21%
2015 450.297.000 14.38%
2016 488.947.000 7.9%
2017 388.348.000 -25.9%
2018 545.473.000 28.81%
2019 284.000.000 -92.07%
2020 449.000.000 36.75%
2021 274.000.000 -63.87%
2022 120.400.000 -127.57%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Ramsay Health Care Limited Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1996 0
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 1 0%
2016 1 0%
2017 0 0%
2018 1 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Ramsay Health Care Limited Free Cashflow
Year Free Cashflow Growth
1996 -46.709.000
1997 -90.914.000 48.62%
1998 -88.694.000 -2.5%
1999 -9.705.000 -813.9%
2000 39.210.000 124.75%
2001 28.632.000 -36.94%
2002 -80.698.000 135.48%
2003 39.629.000 303.63%
2004 51.086.000 22.43%
2005 26.589.000 -92.13%
2006 4.181.000 -535.95%
2007 -31.330.000 113.35%
2008 -25.533.000 -22.7%
2009 162.299.000 115.73%
2010 215.634.000 24.73%
2011 211.680.000 -1.87%
2012 184.835.000 -14.52%
2013 315.848.000 41.48%
2014 260.063.000 -21.45%
2015 394.705.000 34.11%
2016 451.732.000 12.62%
2017 520.846.000 13.27%
2018 309.507.000 -68.28%
2019 1.000.100.000 69.05%
2020 852.300.000 -17.34%
2021 7.000.000 -12075.71%
2022 0 0%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Ramsay Health Care Limited Operating Cashflow
Year Operating Cashflow Growth
1996 9.153.000
1997 0 0%
1998 0 0%
1999 0 0%
2000 52.240.000 100%
2001 65.775.000 20.58%
2002 0 0%
2003 73.741.000 100%
2004 112.777.000 34.61%
2005 128.044.000 11.92%
2006 152.019.000 15.77%
2007 166.714.000 8.81%
2008 241.746.000 31.04%
2009 337.311.000 28.33%
2010 430.591.000 21.66%
2011 433.893.000 0.76%
2012 450.409.000 3.67%
2013 561.512.000 19.79%
2014 746.235.000 24.75%
2015 904.969.000 17.54%
2016 882.187.000 -2.58%
2017 994.687.000 11.31%
2018 903.300.000 -10.12%
2019 1.680.700.000 46.25%
2020 1.481.200.000 -13.47%
2021 715.500.000 -107.02%
2022 0 0%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Ramsay Health Care Limited Capital Expenditure
Year Capital Expenditure Growth
1996 55.862.000
1997 90.914.000 38.56%
1998 88.694.000 -2.5%
1999 9.705.000 -813.9%
2000 13.030.000 25.52%
2001 37.143.000 64.92%
2002 80.698.000 53.97%
2003 34.112.000 -136.57%
2004 61.691.000 44.71%
2005 101.455.000 39.19%
2006 147.838.000 31.37%
2007 198.044.000 25.35%
2008 267.279.000 25.9%
2009 175.012.000 -52.72%
2010 214.957.000 18.58%
2011 222.213.000 3.27%
2012 265.574.000 16.33%
2013 245.664.000 -8.1%
2014 486.172.000 49.47%
2015 510.264.000 4.72%
2016 430.455.000 -18.54%
2017 473.841.000 9.16%
2018 593.793.000 20.2%
2019 680.600.000 12.75%
2020 628.900.000 -8.22%
2021 708.500.000 11.24%
2022 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Ramsay Health Care Limited Equity
Year Equity Growth
1996 125.475.000
1997 205.563.000 38.96%
1998 203.477.000 -1.03%
1999 161.315.000 -26.14%
2000 201.206.000 19.83%
2001 223.076.000 9.8%
2002 253.129.000 11.87%
2003 270.589.000 6.45%
2004 799.490.000 66.15%
2005 838.306.000 4.63%
2006 883.320.000 5.1%
2007 913.809.000 3.34%
2008 908.775.000 -0.55%
2009 1.235.274.000 26.43%
2010 1.313.421.000 5.95%
2011 1.414.006.000 7.11%
2012 1.543.880.000 8.41%
2013 1.702.559.000 9.32%
2014 1.859.831.000 8.46%
2015 2.022.889.000 8.06%
2016 2.276.188.000 11.13%
2017 2.447.409.000 7%
2018 3.023.070.000 19.04%
2019 4.235.900.000 28.63%
2020 4.550.800.000 6.92%
2021 4.526.200.000 -0.54%
2022 4.823.200.000 6.16%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Ramsay Health Care Limited Assets
Year Assets Growth
1996 355.539.000
1997 458.202.000 22.41%
1998 521.431.984 12.13%
1999 467.440.000 -11.55%
2000 510.660.000 8.46%
2001 545.206.000 6.34%
2002 654.052.000 16.64%
2003 690.169.000 5.23%
2004 2.830.048.000 75.61%
2005 2.191.055.000 -29.16%
2006 2.187.831.000 -0.15%
2007 3.091.198.000 29.22%
2008 3.187.128.000 3.01%
2009 3.576.379.000 10.88%
2010 3.551.463.000 -0.7%
2011 3.585.949.000 0.96%
2012 4.062.391.000 11.73%
2013 4.550.799.000 10.73%
2014 7.616.978.000 40.25%
2015 8.264.524.000 7.84%
2016 8.335.361.000 0.85%
2017 9.312.869.000 10.5%
2018 12.532.641.000 25.69%
2019 18.058.700.000 30.6%
2020 19.324.600.000 6.55%
2021 19.473.300.000 0.76%
2022 21.030.200.000 7.4%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Ramsay Health Care Limited Liabilities
Year Liabilities Growth
1996 230.064.000
1997 252.639.000 8.94%
1998 317.955.000 20.54%
1999 306.125.000 -3.86%
2000 309.454.000 1.08%
2001 322.130.000 3.94%
2002 400.923.000 19.65%
2003 419.580.000 4.45%
2004 2.029.931.000 79.33%
2005 1.352.481.000 -50.09%
2006 1.304.194.000 -3.7%
2007 2.177.034.000 40.09%
2008 2.277.966.000 4.43%
2009 2.352.436.000 3.17%
2010 2.247.600.000 -4.66%
2011 2.179.748.000 -3.11%
2012 2.520.576.000 13.52%
2013 2.807.155.000 10.21%
2014 5.783.891.000 51.47%
2015 6.218.463.000 6.99%
2016 5.976.675.000 -4.05%
2017 6.865.460.000 12.95%
2018 9.509.571.000 27.8%
2019 13.822.800.000 31.2%
2020 14.773.800.000 6.44%
2021 14.947.100.000 1.16%
2022 16.207.000.000 7.77%

Ramsay Health Care Limited Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
65.69
Net Income per Share
1.16
Price to Earning Ratio
11.09x
Price To Sales Ratio
0.79x
POCF Ratio
0
PFCF Ratio
0
Price to Book Ratio
0.71
EV to Sales
1.54
EV Over EBITDA
17.8
EV to Operating CashFlow
0
EV to FreeCashFlow
0
Earnings Yield
0.09
FreeCashFlow Yield
0
Market Cap
11,80 Bil.
Enterprise Value
23,03 Bil.
Graham Number
21.86
Graham NetNet
-59.67

Income Statement Metrics

Net Income per Share
1.16
Income Quality
0
ROE
0.06
Return On Assets
0.04
Return On Capital Employed
0.05
Net Income per EBT
2.14
EBT Per Ebit
0.49
Ebit per Revenue
0.05
Effective Tax Rate
0.36

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.09
Operating Profit Margin
0.05
Pretax Profit Margin
0.03
Net Profit Margin
0.05

Dividends

Dividend Yield
0.01
Dividend Yield %
0.93
Payout Ratio
0
Dividend Per Share
0.12

Operating Metrics

Operating Cashflow per Share
0
Free CashFlow per Share
0
Capex to Operating CashFlow
0
Capex to Revenue
0
Capex to Depreciation
0
Return on Invested Capital
0.02
Return on Tangible Assets
0.02
Days Sales Outstanding
55.29
Days Payables Outstanding
40.68
Days of Inventory on Hand
10.65
Receivables Turnover
6.6
Payables Turnover
8.97
Inventory Turnover
34.27
Capex per Share
0

Balance Sheet

Cash per Share
3,16
Book Value per Share
18,24
Tangible Book Value per Share
-5.88
Shareholders Equity per Share
18.24
Interest Debt per Share
52.18
Debt to Equity
2.86
Debt to Assets
0.57
Net Debt to EBITDA
8.68
Current Ratio
1.02
Tangible Asset Value
-1,34 Bil.
Net Current Asset Value
-12,31 Bil.
Invested Capital
2.86
Working Capital
0,09 Bil.
Intangibles to Total Assets
0.29
Average Receivables
1,13 Bil.
Average Payables
0,74 Bil.
Average Inventory
194300000
Debt to Market Cap
1.01

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Ramsay Health Care Limited Dividends
Year Dividends Growth
2021 0
2022 0 0%
2023 0 0%

Ramsay Health Care Limited Profile

About Ramsay Health Care Limited

Ramsay Health Care Limited owns and operates hospitals for public and private patients. It also offers health care services. It operates facilities in 460 locations in the Asia Pacific, the United Kingdom, France, and Nordics. The company was founded in 1964 and is based in Sydney, Australia.

CEO
Mr. Craig Ralph McNally
Employee
88.000
Address
126 Phillip Street
Sydney, 2000

Ramsay Health Care Limited Executives & BODs

Ramsay Health Care Limited Executives & BODs
# Name Age
1 Dr. Rachna Gandhi
Global Chief Digital & Data Officer
70
2 Doug Meagher
Chief Financial Officer of Ramsay Australia
70
3 Ms. Henrietta Rowe BECON, L.L.B.
Group General Counsel & Company Secretary
70
4 Sir Edward Byrne AC, DSc, FMEDSCI, FRACP, FRCP, FTSE, M.D., MBA
Group Chief Medical Officer
70
5 Ms. Carmel Monaghan
Chief Executive Officer of Ramsay Australia
70
6 Mr. Craig Ralph McNally
Chief Executive Officer, MD & Executive Director
70
7 Mr. Martyn J. Roberts
Group Chief Financial Officer
70
8 Ms. Kelly Hibbins
Group Head of Investor Relations
70
9 Ms. Colleen Harris
Group Chief People Officer
70
10 Mr. Andrew Wearne
Group Chief Risk Officer
70

Ramsay Health Care Limited Competitors